Market Overview

UPDATE: Bank of America Initiates Coverage on The Advisory Board Company on Rare Healthcare Growth Story

Share:
Related ABCO
Wall Street's M&A Chatter From April 27: Advisory Board, Whole Foods, SiriusXM-Automatic Labs, Apollo-West Corp
Chances Of Advisory Board Getting Taken Out Just Got Considerably Higher
Pivot Point Capital Partners, LLC Buys Shutterfly Inc, Sells Carter's Inc, Monro Muffler Brake ... (GuruFocus)

In a report published Friday, Bank of America analyst Robert M. Willoughby initiated coverage on The Advisory Board Company (NASDAQ: ABCO) with a Buy rating and $67.00 price target.

In the report, Bank of America noted, “Medicare/Medicaid entitlement cuts, changing payment models, and health care reform uncertainties are contributing to an increasingly complex health care environment, but these industry dynamics are a boon for ABCO, which helps providers execute operationally and strategically. It plans to grow by cross-selling new and existing solutions within its existing membership base, attracting new members, building and/or acquiring new software capabilities, and realizing greater economies of scale on a primarily fixed cost base. We forecast visible, long-term annual EPS growth of 15%, compelling relative to most of the other names in our coverage universe, with low invested capital requirements.”

The Advisory Board Company closed on Thursday at $58.15.

Latest Ratings for ABCO

DateFirmActionFromTo
Mar 2017BairdUpgradesOutperform
Mar 2017SunTrust Robinson HumphreyDowngradesBuyHold
Jan 2017PiperJaffrayDowngradesOverweightNeutral

View More Analyst Ratings for ABCO
View the Latest Analyst Ratings

Posted-In: Bank of America Robert M. WilloughbyAnalyst Color Initiation Analyst Ratings

 

Related Articles (ABCO)

View Comments and Join the Discussion!